Zobrazeno 1 - 10
of 27
pro vyhledávání: '"G. Yildirim-Cetin"'
Autor:
C. Akleylek, S. Akar, H. Cinakli, R. Piskin Sagir, B. N. Coşkun, A. Karakas, H. Apaydin, R. C. Kardaş, O. Ozdemir Isik, S. Hakbilen, B. Okyar, O. Sosyal, S. S. Koca, Y. Pehlivan, E. Dalkiliç, G. Can, İ. Sari, M. Birlik, F. Onen, S. Erten, M. A. Ozturk, A. Yazici, A. Cefle, S. Yilmaz, G. Yildirim Cetin, N. Akkoc, N. Yilmaz
Publikováno v:
Annals of the Rheumatic Diseases. 81:1507-1508
BackgroundSecukinumab (SEC), a human anti-IL-17A monoclonal antibody, has similar treatment response rates to tumor necrosis factor (TNF) inhibitors in patients with axial spondyloarthritis (SpA). However, the efficacy of SEC on anterior uveitis (AU)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46a0dee62c20b4b6901f60b04b99f15b
https://doi.org/10.1136/annrheumdis-2022-eular.2248
https://doi.org/10.1136/annrheumdis-2022-eular.2248
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
T. Demirci Yildirim, C. Akleylek, H. Cinakli, D. Yildirim, S. Hakbilen, B. N. Coşkun, B. Okyar, O. Ozdemir Isik, R. Piskin Sagir, H. Apaydin, S. Gulle, Y. Erez, T. Yuce Inel, N. Yilmaz, S. Akar, A. Tufan, S. Yilmaz, Y. Pehlivan, G. Yildirim Cetin, A. Cefle, S. S. Koca, S. Erten, A. Yazici, E. Dalkiliç, G. Can, İ. Sari, M. Birlik, F. Onen
Publikováno v:
Annals of the Rheumatic Diseases. 81:1662.3-1663
BackgroundConsidering the concerns regarding COVID-19 vaccine safety among patients with rheumatic diseases due to a lack of data, an urgent need for studies evaluating safety profiles of vaccines emerged.ObjectivesVaccination against the coronavirus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66be93fcff056f6a50cfa3d3272691a6
https://doi.org/10.1136/annrheumdis-2022-eular.390
https://doi.org/10.1136/annrheumdis-2022-eular.390
Autor:
G. Yildirim Cetin, A. Avanoğlu Güler, Suleyman Yilmaz, Süleyman Serdar Koca, Fatos Onen, R. Piskin Sagir, Ahmet Karataş, Soner Senel, O. Sosyal, Pamir Atagündüz, Servet Akar, Ayten Yazici, Yavuz Pehlivan, Nevsun Inanc
Publikováno v:
Annals of the Rheumatic Diseases. 80:1266.3-1267
Background:Choosing the best treatment strategy for a patient is one of the most difficult issues in modern rheumatology, as there are various factors affecting drug therapy in chronic diseases, such as efficacy, safety, and compliance. Physicians ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5a5f8ee54dd00c460e343db9eae0c6b
https://doi.org/10.1136/annrheumdis-2021-eular.3140
https://doi.org/10.1136/annrheumdis-2021-eular.3140
Autor:
Umut Kalyoncu, Orhan Küçükşahin, Meryem Can, Levent Kilic, Ediz Dalkilic, Emine Figen Tarhan, Cem Ozisler, Gezmiş Kimyon, Ahmet Omma, Ilaria Tinazzi, Dilek Solmaz, Sibel Zehra Aydin, Ozun Bayindir, G. Yildirim Cetin, Sibel Bakirci, Servet Akar, Suleyman Yilmaz, Sule Yavuz, Atalay Dogru
Publikováno v:
Annals of the Rheumatic Diseases. 79:1176.2-1177
Background:Methotrexate (MTX) is the most common first-line disease-modified anti-rheumatic drugs in psoriatic arthritis (PsA), despite the controversies.Objectives:In this study, we aimed to determine the rate of withdrawal rate of MTX in PsA and re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::091b570c005649bcfb1172524e7ecb91
https://doi.org/10.1136/annrheumdis-2020-eular.2710
https://doi.org/10.1136/annrheumdis-2020-eular.2710
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Annals of the Rheumatic Diseases. 74:1114.4-1115
Background Oxidative stress may have crucial role in the pathogenesis of BD. Thiol groups are important members of the antioxidants. However there is no automatic colorimetric method for measuring the level of plasma/serum dynamic disulfide level. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d27761fb5450ed8dedadaa504e96fc3
https://doi.org/10.1136/annrheumdis-2015-eular.2195
https://doi.org/10.1136/annrheumdis-2015-eular.2195
Autor:
N. Yilmaz, O.N. Pamuk, Fatma Alibaz-Oner, Kenan Aksu, S. Bas, Murat Can, Nevsun Inanc, Sevdiye Ersoy Yilmaz, Havva Keskin, Ayhan Onat, S. Senel, Gulsen Ozen, Ali Sahin, Ilker Yagci, Yonca Cagatay, Lütfi Akyol, G. Yildirim-Cetin, S. Murat, Kevser Gok, Pamir Atagündüz, Alperen Mengi, Gezmiş Kimyon, Haner Direskeneli, Veli Cobankara, Mehmet Sayarlioglu, O. Bayindir, Ayse Balkarli, Ali Ugur Unal, Suna Aydin
Publikováno v:
Annals of the Rheumatic Diseases. 74:520.2-520
Objectives To evaluate the diagnostic and discriminative ability of the new 2012 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) polymyalgia rheumatica (PMR) classification criteria compared to previous five diagnost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3fd97ee49d7c8a1eb22b723e2aa57d3
https://doi.org/10.1136/annrheumdis-2015-eular.2285
https://doi.org/10.1136/annrheumdis-2015-eular.2285
Publikováno v:
Annals of the Rheumatic Diseases. 74:1010.2-1010
Objectives Nowadays, Rheumatoid Arthritis (RA) is known to be associated with cardiovascular diseases. However,the subject of risk factor that rheumatoid arthritis for cerebrovascular diseases is controversial. In our study, We examined the effects o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b83f2ff1fb34de7c23e5b88335d3d5b
https://doi.org/10.1136/annrheumdis-2015-eular.4161
https://doi.org/10.1136/annrheumdis-2015-eular.4161
Publikováno v:
Annals of the Rheumatic Diseases. 74:1010.3-1010
Objectives Rituximab is a monoclonal antibody drug used in malignancies and autoimmune diseases. Rituximab used for improving the symptoms and preventing rheumatic disease. We examined the effects of rituximab treatment on the cerebral blood flow vel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ba13938a7c1ff49ff2574df06b4123e
https://doi.org/10.1136/annrheumdis-2015-eular.4173
https://doi.org/10.1136/annrheumdis-2015-eular.4173